Get the Stockscreener App
2.03
2.53%
0.05
Pre-market:
2.08
0.05
+2.46%
Cardio Diagnostics Holdings Inc stock is traded at $2.03, with a volume of 63,654.
It is up +2.53% in the last 24 hours and down -61.70% over the past month.
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases and associated comorbidities by leveraging its Artificial Intelligence (AI)-driven Multi-Omics Engine. The company has developed two clinical products: Epi+Gen CHD and PrecisionCHD, epigenetics-based clinical blood tests capable of assessing risk for a coronary heart disease (CHD) event, including heart attacks. Additionally, its portfolio includes HeartRisk, a cardiovascular disease risk intelligence platform, and CardioInnovate360, a research-use-only solution launched to support the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases.
See More
Previous Close:
$1.98
Open:
$2.03
24h Volume:
63,654
Relative Volume:
0.02
Market Cap:
$6.01M
Revenue:
$14,800
Net Income/Loss:
$-6.50M
P/E Ratio:
-0.5464
EPS:
-3.7153
Net Cash Flow:
$-6.15M
1W Performance:
+4.10%
1M Performance:
-61.70%
6M Performance:
-53.55%
1Y Performance:
-79.32%
1-Day Range:
$1.84
$2.04
1-Week Range:
$1.84
$2.17
52-Week Range:
$0.97
$17.39
Cardio Diagnostics Holdings Inc Stock (CDIO) Company Profile
Name
Cardio Diagnostics Holdings Inc
Sector
Industry
Phone
855-226-9991
Address
311 W. SUPERIOR STREET, CHICAGO
Compare CDIO vs VRTX, REGN, ARGX, ALNY, INSM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDIO
Cardio Diagnostics Holdings Inc
|
2.03 | 6.01M | 14,800 | -6.50M | -6.15M | -3.7153 |
VRTX
Vertex Pharmaceuticals Inc
|
431.86 | 109.85B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
760.27 | 80.38B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
765.43 | 47.60B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
319.52 | 42.63B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
163.03 | 35.19B | 606.42M | -1.28B | -997.58M | -6.403 |
Cardio Diagnostics Holdings Inc Stock (CDIO) Latest News
Dividend Watch: What is the earnings history of Cardio Diagnostics Holdings IncEarnings Recap Summary & Precise Buy Zone Tips - baoquankhu1.vn
Aug Catalysts: What is Cardio Diagnostics Holdings Inc Equity Warrants 5 year growth outlookQuarterly Market Summary & Fast Gaining Stock Reports - baoquankhu1.vn
S P Trends: What is Cardio Diagnostics Holdings Inc Equity Warrants 5 year growth outlookDividend Hike & Daily Stock Trend Reports - baoquankhu1.vn
Shorts Report: Can Cardio Diagnostics Holdings Inc ride the EV wave2026 Retail & Real-Time Volume Analysis Alerts - baoquankhu1.vn
Resistance Check: Can Cardio Diagnostics Holdings Inc ride the EV wave2026 WrapUp & Weekly Market Pulse Updates - baoquankhu1.vn
Financial Review: Cardio Diagnostics (NASDAQ:CDIO) versus Avidity Biosciences (NASDAQ:RNA) - Defense World
Cardio Diagnostics (CDIO) director receives 3,205 stock options at $1.95 exercise price - Stock Titan
[Form 4] Cardio Diagnostics Holdings, Inc. Insider Trading Activity - Stock Titan
Cardio Diagnostics (CDIO) director granted 3,205 options at $1.95 - Stock Titan
Cardio Diagnostics director receives option grant | CDIO Insider Trading - Stock Titan
Institution Moves: Will Cardio Diagnostics Holdings Inc benefit from government policyEarnings Risk Report & Weekly High Conviction Trade Ideas - baoquankhu1.vn
CDIO Stock Price, Quote & Chart | CARDIO DIAGNOSTICS HOLDINGS (NASDAQ:CDIO) - ChartMill
Breakout Move: What is the implied volatility of Cardio Diagnostics Holdings Inc2026 Earnings Impact & Trade Opportunity Analysis - baoquankhu1.vn
Cardio Diagnostics Holdings (CDIO) Is 'One to Watch' - finance.yahoo.com
Cardio Diagnostics Holdings (NASDAQ: CDIO) Is ‘One to Watch’ - tradingview.com
CDIO Technical Analysis & Stock Price Forecast - Intellectia AI
Aug Intraday: Can Cardio Diagnostics Holdings Inc continue delivering strong returns2026 Highlights & AI Powered Trade Plan Recommendations - baoquankhu1.vn
Panic Selling: Is Cardio Diagnostics Holdings Inc vulnerable to short sellers2026 Market Trends & Reliable Intraday Trade Alerts - baoquankhu1.vn
Heart Attack Diagnostics Market (2026-2033) | Troponin - openPR.com
Targets Report: Will Absci Corporation benefit from government policy2026 Weekly Recap & Weekly High Potential Stock Alerts - baoquankhu1.vn
Volume Summary: What are Cardio Diagnostics Holdings Incs recent SEC filings showingQuarterly Portfolio Review & Expert Curated Trade Ideas - baoquankhu1.vn
Pullback Watch: How does Cardio Diagnostics Holdings Inc score in quality rankingsBuy Signal & Technical Confirmation Trade Alerts - baoquankhu1.vn
CDIO Should I Buy - Intellectia AI
Bearish Setup: What is Cardio Diagnostics Holdings Inc Equity Warrants 5 year growth outlook2026 Weekly Recap & Real-Time Market Trend Scan - baoquankhu1.vn
CDIO Price Today: Cardio Diagnostics Holdings Inc. Stock Price, Quote & Chart - MEXC Exchange
Insider Sell: What is the dividend yield of Cardio Diagnostics Holdings Inc Equity Warrant2026 Drop Watch & Proven Capital Preservation Tips - baoquankhu1.vn
CDIO SEC FilingsCardio Diagnostics Holdings Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Exit Recap: What is the earnings history of Cardio Diagnostics Holdings Inc2026 Chart Watch & Safe Capital Allocation Plans - baoquankhu1.vn
If You Invested $1,000 in Cardio Diagnostics Holdings Inc (CDIO) - Stock Titan
Pullback Watch: What is the implied volatility of Cardio Diagnostics Holdings Inc2026 Recap & Fast Moving Stock Trade Plans - baoquankhu1.vn
Cardio Diagnostics (CDIO) details AI heart tests, reverse split and ATM share sales - Stock Titan
AI-Driven Multi-Omics Solutions for Early Detection and Risk Assessment of Cardiovascular Disease by Cardio Diagnostics Holdings, Inc. 5765687778 - Minichart
Cardio Diagnostics 2025 10-K: Revenue $14,825, EPS $(3.71) - TradingView
12 Health Care Stocks Moving In Friday's Intraday SessionAditxt (NASDAQ:ADTX), Firefly Neuroscience (N - Benzinga
Cardio Diagnostics drops on 1-for-30 reverse stock split - MSN
Aug Big Picture: Is now the right time to enter Cardio Diagnostics Holdings IncEarnings Recap Report & AI Enhanced Trading Signals - baoquankhu1.vn
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Bull Run: What is the implied volatility of Cardio Diagnostics Holdings Inc2026 Earnings Impact & Daily Growth Stock Investment Tips - baoquankhu1.vn
Cardio Diagnostics announces 1-for-30 reverse stock split - MSN
Market Review: Can Cardio Diagnostics Holdings Inc continue delivering strong returnsWeekly Stock Report & Intraday High Probability Setup Alerts - baoquankhu1.vn
Institution Moves: Is Cardio Diagnostics Holdings Inc Equity Warrant a top pick in the sectorM&A Rumor & Accurate Intraday Trading Signals - baoquankhu1.vn
Rally Mode: How much upside does Dave Inc Equity Warrant haveFed Meeting & Verified Momentum Stock Watchlist - baoquankhu1.vn
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
10 Health Care Stocks Moving In Monday's Pre-Market Session - Sahm
CDIO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Cardio Diagnostics to Host Investor Call on AI-Driven Cardiovascular Platform - StocksToTrade
Cardio Diagnostics to Highlight Strategic Growth in Upcoming Investor Call - timothysykes.com
Key Market Insights - StocksToTrade
Cardio Diagnostics Holdings Inc.Warrant (Nasdaq:CDIOW) Stock Quote - FinancialContent
Cardio Diagnostics to Unveil AI-Powered Precision Health Platform at Investor Call - timothysykes.com
CDIO’s Strategic Growth: New AI Platform Shapes Future - StocksToTrade
Cardio Diagnostics Holdings Inc Stock (CDIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.47%
2.75%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):